Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Peter Gibson (Newcastle, Australia). Inflammatory phenotypes of COPD. International Congress 2015 – Individualised risk reduction strategies for patients with COPD

Member's Comments

No comment yet.

Related content which might interest you: Inflammatory markers in COPD patients with and without cachexia Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Inflammatory markers in relation to cachexia in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003 Inflammatory phenotypes of severe exacerbation of COPD, a clinico-laboratory characterization. Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Inflammatory bowel diseases in COPD patients. Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Relation of inflammatory process with COPD phenotype Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Inflammatory cells and airway remodelling in COPD Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 Inflammatory mediators in COPD patients with and without alpha-1-antitrypsin deficiency Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Inflammatory cell phenotypes in bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 484s Year: 2005 Endothelial dysfunction and systemic inflammation in different COPD phenotypes Source: International Congress 2014 – COPD physiopathology Year: 2014 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Inflammatory molecular endotypes in bronchiectasis Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 Inflammatory markers of atherogenesis in patients with uncontrolled severe asthma Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012 Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011